Clinical trial
Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion
NCT01353105 is registered in ClinicalTrials.gov with InCor Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion
- Lead sponsor
- InCor Heart Institute
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- August 31, 2015
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.